Premium
O4–06–07: MMP–9 degrades fibrilllar abeta in vitro and compact plaques In situ
Author(s) -
Lee Jin-Moo,
Hu Xiaoyan,
Crick Scott,
Song Haowei,
Yin Kejie,
Cirrito John,
Bateman Randy,
Hsu Chung Y.,
Xu Jan,
Hsu Fong F.,
Turk John,
Pappu Rohit,
Holtzman David M.,
Yan Ping
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.342
Subject(s) - proteases , chemistry , matrix metalloproteinase , protease , enzyme , senile plaques , staining , in vivo , metalloproteinase , in vitro , fluorescence microscope , proteolysis , paraformaldehyde , microbiology and biotechnology , biophysics , biochemistry , fluorescence , pathology , biology , alzheimer's disease , medicine , physics , disease , organic chemistry , quantum mechanics
null background. We are performing A ELISAs, immunoblotting, and immunohisto-chemistry on brains from these mice and their APP transgenic controls collected at 3, 6, and 13 months of age. Results: The absence of NEP results in: a) elevations in the TBS-, NP40-, and guanidine HCl-soluble pools of brain A ; b) marked elevations in hippocampal amyloid plaque burden; and c) a dramatic increase in amyloid angiopathy. We will report further on plasma A levels, A monomer, dimer, and oligomer levels, and the possibility of a NEP gene-dose response. Conclusions: The absence of endogenous NEP in human APP transgenic mice results in elevated levels of brain A , an increased amyloid plaque burden, and the development of amyloid angiopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom